言語を選択

c-Myc

c-Myc 詳細

英語名	Myc proto-oncogene protein	市販薬剤の数	0
治験薬の数	10	ターゲットの別称	Class E Basic Helix-Loop-Helix Protein 39，Transcription Factor P64，Proto-Oncogene C-Myc，Myc-Related Translation/Localization Regulatory Factor，Avian Myelocytomatosis Viral Oncogene Homolog，V-Myc Myelocytomatosis Viral Oncogene Homolog，Myc Proto-Oncogene Protein，BHLHE39，C-Myc，MRTL，MYCC，Proto-Oncogene Proteins c-myc，MYC，MYC Proto-Oncogene， BHLH Transcription Factor，V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
研究＆開発段階	Phase 2 Clinical

英語名	Myc proto-oncogene protein
ターゲットの別称	Class E Basic Helix-Loop-Helix Protein 39，Transcription Factor P64，Proto-Oncogene C-Myc，Myc-Related Translation/Localization Regulatory Factor，Avian Myelocytomatosis Viral Oncogene Homolog，V-Myc Myelocytomatosis Viral Oncogene Homolog，Myc Proto-Oncogene Protein，BHLHE39，C-Myc，MRTL，MYCC，Proto-Oncogene Proteins c-myc，MYC，MYC Proto-Oncogene， BHLH Transcription Factor，V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
市販薬剤の数	0
治験薬の数	10
研究＆開発段階	Phase 2 Clinical

c-Myc 製品リスト

属性
Antibody (1)
製品ライブラリ
オンライン (1)
種
Mouse (1)
タグ
- (1)
マーカー
Unconjugated (1)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
MYC-MMYCc	Mouse	HEK293	Anti c-Myc Tag Monoclonal Antibody (9E10)

総数量1

c-Mycバックグランド

The c-Myc tag is a widely used epitope tag in molecular biology for protein expression and detection. Derived from the human c-Myc oncoprotein. This tag is typically fused to target proteins through genetic engineering, allowing researchers to identify, purify, or track the expressed proteins using specific monoclonal antibodies.

c-Myc分子の別称

c-Myc,MYC,MRTL,bHLHe39

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
XNW-34017	XNW-34017; XNW34017	Phase 2 Clinical	Evopoint Biosciences Co Ltd	Neoplasm Metastasis; Solid tumours	詳細
Sepantronium Bromide	YM-155; YM155 monobromide; PC-002	Phase 2 Clinical	Astellas Pharma Inc	Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Lymphatic Diseases; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Prostatic Neoplasms; Solid tumours	詳細
OMO-103	OMO-103; OMO103	Phase 2 Clinical	Peptomyc SL	Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Osteosarcoma; Pancreatic Neoplasms; Solid tumours	詳細
WP-1066	WP-1066	Phase 2 Clinical	Moleculin Biotech Inc	Brain metastases; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Medulloblastoma; Melanoma	詳細
PLX-51107	PLX-51107	Phase 1 Clinical	Plexxikon Inc	Graft vs Host Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Solid tumours	詳細
SACT-1	SACT-1	Phase 1 Clinical	Aptorum Group Llc	Neuroblastoma	詳細
Myrtleciclib	VS 2370; VS2-370	Phase 1 Clinical	Vichem Chemie	HIV Infections; Neoplasms	詳細
WBC100	WBC100; WBC-100	Phase 1 Clinical	Hangzhou Weben Pharmaceutical Co Ltd	Hematologic Neoplasms; Leukemia, Myeloid, Acute; Neoplasms; Solid tumours	詳細
Luxeptinib	CG026806; CG-806; CG’806; CG-026806	Phase 1 Clinical	Crystalgenomics Inc	Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes	詳細
Misetionamide	GP-2250	Phase 1 Clinical	Geistlich Pharma	Pancreatic Neoplasms	詳細